|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 38/17 | |||
| C07K 14/705 | |||
| G01N 33/50 | |||
| G01N 33/68 | |||
| A61P 35/00 |
| (11) | Number of the document | 2480575 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10766312.2 |
| Date of filing the European patent application | 2010-09-22 | |
| (97) | Date of publication of the European application | 2012-08-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2010/001776 |
| Date | 2010-09-22 |
| (87) | Number | WO 2011/036440 |
| Date | 2011-03-31 |
| (30) | Number | Date | Country code |
| 0916686 | 2009-09-23 | GB |
| (72) |
CHEN, Min-Che, GB
|
| (73) |
Asclepiumm Limited,
17 Block A Pollard Street, Manchester M4 7AJ,
GB
|
| (54) | ANTAGONISTS OF DSG2 FOR TREATMENT OF CANCER |
| ANTAGONISTS OF DSG2 FOR TREATMENT OF CANCER |